AMY HAHN: Open Payments
NPI 1487668539 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,123 in 106 payments from 16 companies in 2025. Trend: 2023 $2,336 · 2024 $2,111 · 2025 $2,123
Food & beverage: $2,123
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $465 |
| Janssen Biotech, Inc. | 13 | $272 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $227 |
| Incyte Corporation | 8 | $206 |
| Galderma Laboratories, L.P. | 10 | $206 |
| GENZYME CORPORATION | 6 | $159 |
| Regeneron Healthcare Solutions, Inc. | 4 | $128 |
| UCB, Inc. | 4 | $127 |
| Botanix SB Inc | 4 | $97 |
| Organon LLC | 9 | $88 |
Products named: RINVOQ, DUPIXENT, TREMFYA, ILUMYA, OPZELURA, SKYRIZI, NEMLUVIO, Bimzelx.
Industry payments across PA — which companies pay providers there.
